BioDlink International Company Limited (1875.HK) HKSE
4.70
-0.05(-1.05%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
4.70
-0.05(-1.05%)
Currency In HKD
Address
No. 120 Changyang Street
Suzhou, 215024
China
Phone
86 512 6296 5186
Sector
Healthcare
Industry
Biotechnology
Employees
611
First IPO Date
November 08, 2019
| Name | Title | Pay | Year Born |
| Li Yin | Chief Technology Officer | 0 | 1966 |
| Jincai Li | Executive Director | 0 | 1973 |
| Jian Bo Zhang | Chief Operating Officer | 0 | 1978 |
| Shan Fu | Executive Chairperson of the Board | 0 | 1969 |
| Wing Yat Lui | Joint Company Secretary | 0 | 1990 |
| Yifan Chen | Joint Company Secretary | 0 | 1980 |
| Ben Xiao | Group Vice President of Finance & Investor Relations | 0 | 1982 |
BioDlink International Co., Ltd. is clinical stage biopharmaceutical company, which engages in developing and commercializing oncology drugs and therapies. Its product portfolio includes: TAB008, TOZ309, TAA013, TAE020, TAB 014, and TAC020. The company was founded on December 4, 2009 and is headquartered in Suzhou, China.